Prostatic Neoplasms
Showing NaN - NaN of 26
Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)
Recruiting
- Prostatic Neoplasms
- +16 more
- Abemaciclib
- +3 more
-
Birmingham, Alabama
- +296 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Anchorage, Alaska
- +163 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
- +3 more
-
Phoenix, Arizona
- +183 more
Jan 17, 2023
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Docetaxel, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +4 more
-
Mobile, Alabama
- +214 more
Nov 24, 2022
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Enzalutamide, Placebo)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +2 more
-
Mobile, Alabama
- +257 more
Nov 22, 2022
Prostatic Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Prostatic Neoplasms
-
Tucson, Arizona
- +109 more
Aug 2, 2022
Imperial Prostate 6 - Cancer Histology Artificial Intelligence
Recruiting
- Prostatic Neoplasms
- Biopsy & Imaging
-
Coventry, United Kingdom
- +5 more
Mar 29, 2022
Prostatic Tumors Trial in Worldwide (Enzalutamide, NSAA, LHRHA or Surgical Castration)
Active, not recruiting
- Prostatic Neoplasms
- Enzalutamide
- +2 more
-
Boston, Massachusetts
- +81 more
Oct 7, 2021
Prostatic Tumors Trial in Worldwide (Enzalutamide, Conventional NSAA, LHRHA)
Active, not recruiting
- Prostatic Neoplasms
- Enzalutamide
- +3 more
-
Boston, Massachusetts
- +68 more
Apr 1, 2021
Metastatic Cancer of Prostate: A Study of ZYTIGA Use in
Completed
- Prostatic Neoplasms
- Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry
-
Calgary, Alberta, Canada
- +40 more
Dec 5, 2019
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))
Completed
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
-
Scottsdale, Arizona
- +67 more
Jun 30, 2019
Prostatic Tumors, Diagnostic Techniques and Procedures Trial in London (SmartTarget - Biopsy)
Completed
- Prostatic Neoplasms
- Diagnostic Techniques and Procedures
- SmartTarget - Biopsy
-
London, United KingdomUniversity College London
Jan 29, 2019
Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, mitoxantrone, prednisone)
Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, prednisone)
Completed
- Prostate Cancer
- +3 more
-
Birmingham, Alabama
- +263 more
Feb 14, 2018
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (BAY88-8223))
Completed
- Prostatic Neoplasms
- Radium-223 dichloride (BAY88-8223)
-
Brugge, Belgium
- +214 more
Mar 30, 2017
PRIME - PRostate Imaging for Margin Evaluation
Completed
- Prostatic Neoplasms
-
London, United KingdomUniversity College Hospital London
Jun 22, 2016
Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)
Completed
- Prostatic Neoplasms
- Placebo
- +2 more
-
Birmingham, Alabama
- +127 more
Apr 10, 2014
Prostatic Tumors Trial in Worldwide (Docetaxel, Prednisone, Intetumumab)
Prostatic Tumors Trial in Worldwide (Prednisone, sunitinib, Placebo)
Blood Cancer, Breast Cancer, Prostatic Tumors Trial in Stanford, London (Cancer: Thriving and Surviving Online Workshop)
Completed
- Blood Cancer
- +4 more
- Cancer: Thriving and Surviving Online Workshop
-
Stanford, California
- +1 more
Feb 5, 2013
Hormone-Refractory Prostate Cancer, Prostatic Tumors Trial in Worldwide (YM598)
Terminated
- Hormone-Refractory Prostate Cancer
- Prostatic Neoplasms
-
Anchorage, Alaska
- +52 more
Jun 6, 2012